Ipsen S.A. IPN
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Ipsen S.A. is a French biopharmaceutical company headquartered in Paris, specializing in the development and commercialization of transformative medicines across three core therapeutic areas: oncology, rare diseases, and neuroscience. Founded in 1929 by Dr. Henri Beaufour as a family business, it has evolved over nearl…
SectorHealthcare
ExchangeXPAR
IndustryDrug Manufacturers - Specialty & Generic
CountryFrance
Employees5,535
TickerIPN
Statistics
Market Cap$15.21B
Revenue (TTM)$4.63B
Net Income—
Net Margin—
EPS—
P/E29.03
P/S3.29
P/B2.98
EV/EBITDA9.22
ROE10.4%
Dividend Yield4.12%
Price$184.60
Data: Twelve Data · Revenue = mcap / P/S